Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design ...

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...